Home > Healthcare > Bionic Eye Market > Table of Contents

Bionic Eye Market - By Eye Type (External & Implanted Eye), Technology (Electronic, Mechanical), Indication (Vision Loss and Impairment, Retinitis Pigmentosa, Dry Age-related Macular Degeneration), End-use (Hospital, Clinic) – Global Forecast, 2024 – 2032

  • Report ID: GMI8433
  • Published Date: Mar 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definition

1.2    Base estimates & calculations

1.3    Data collection

1.4    Forecast parameters

1.5    Data validation

1.6    Data sources

1.6.1    Primary

1.6.2    Secondary

1.6.2.1   Paid sources

1.6.2.2   Public sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1   Growing prevalence of vision loss and other chronic eye diseases

3.2.1.2   Increasing funding by private and public organizations

3.2.1.3   Rapid advancements in technological developments

3.2.2    Industry pitfalls & challenges

3.2.2.1   Low awareness among target population

3.2.2.2   High costs associated with these procedures

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Technological landscape

3.6    Porter's analysis

3.6.1    Supplier power

3.6.2    Buyer power

3.6.3    Threat of new entrants

3.6.4    Threat of substitutes

3.6.5    Industry rivalry

3.7    PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company market share analysis

4.3    Competitive positioning matrix

4.4    Strategy outlook matrix

Chapter 5   Market Estimates and Forecast, By Eye Type, 2018 – 2032 ($ Mn)

5.1    Key trends

5.2    External eye

5.3    Implanted eye

Chapter 6   Market Estimates and Forecast, By Technology, 2018 – 2032 ($ Mn)

6.1    Key trends

6.2    Electronic

6.3    Mechanical

6.4    Other technologies

Chapter 7   Market Estimates and Forecast, By Indication, 2018 – 2032 ($ Mn)

7.1    Key trends

7.2    Vision loss and impairment

7.3    Retinitis pigmentosa

7.4    Dry age-related macular degeneration

7.5    Other indications

Chapter 8   Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn

8.1    Key trends

8.2    Hospitals

8.3    Ophthalmic clinics

8.4    Other end-users

Chapter 9   Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)

9.1    Key trends

9.2    North America

9.2.1    U.S.

9.2.2    Canada

9.3    Europe

9.3.1    Germany

9.3.2    UK

9.3.3    France

9.3.4    Spain

9.3.5    Italy

9.3.6    Rest of Europe

9.4    Asia Pacific

9.4.1    Japan

9.4.2    China

9.4.3    India

9.4.4    Australia

9.4.5    South Korea

9.4.6    Rest of Asia Pacific

9.5    Latin America

9.5.1    Brazil

9.5.2    Mexico

9.5.3    Argentina

9.5.4    Rest of Latin America

9.6    Middle East and Africa

9.6.1    Saudi Arabia

9.6.2    South Africa

9.6.3    UAE

9.6.4    Rest of Middle East and Africa

Chapter 10   Company Profiles

10.1    Bionic Eye Technologies, Inc.

10.2    Bionic Vision Technologies

10.3    iBionics

10.4    Monash Vision Group

10.5    Nidek Co. Ltd.

10.6    Optobionics

10.7    Pixium Vision SA

10.8    Schott

10.9    Second Sight Medical Products, Inc.

10.10    Vivani Medical, Inc.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 270
  • Countries covered: 22
  • Pages: 130
 Download Free Sample